A self-destructive nanosweeper that captures and clears amyloid β-peptides

Area of Science:

• Biomedical Engineering
• Neuroscience
• Materials Science

Background:

• Alzheimer's disease (AD) is characterized by cerebral amyloid-beta peptide (Aβ) accumulation due to disrupted production-clearance balance.
• Effective Aβ clearance is crucial for maintaining homeostasis and developing novel AD therapies.

Purpose of the Study:

• To develop a self-destructive nanosweeper for capturing and clearing Aβ for AD treatment.
• To investigate the therapeutic potential of peptide-polymer-based nanosweepers in AD.

Main Methods:

• Co-assembly of multifunctional peptide-polymers via hydrogen bonding to create nanosweepers.
• In vitro and in vivo studies to assess Aβ binding, cellular uptake, and autophagy modulation.
• Evaluation of Aβ cytotoxicity reduction and memory deficit rescue in AD transgenic mice.

Main Results:

• Nanosweepers effectively recognized and bound Aβ plaques.
• Aβ-loaded nanosweepers were internalized by cells, upregulating autophagy and promoting Aβ degradation.
• Treatment with nanosweepers decreased Aβ cytotoxicity and rescued memory deficits in AD mouse models.

Conclusions:

• The developed peptide-polymer nanosweepers demonstrate a resourceful and synergistic approach for AD treatment.
• This technology shows significant potential for clearing Aβ and offers a promising therapeutic strategy for Alzheimer's disease.